Clinical Trial Update: Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017) [Phase 3]

View source ↗

Summary

Phase 3 trial update reports long-term safety and tolerability of the ezetimibe and atorvastatin combination in hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Lipitor (atorvastatin)
• Zetia (ezetimibe)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED